Nihon Kohden completed the acquisition of a 71.4% stake in NeuroAdvanced.

Nihon Kohden, a provider of medical device innovation for high-precision patient monitoring and diagnostics, completed the acquisition of a 71.4% stake in NeuroAdvanced, a medical equipment manufacturing company. Financial terms were not disclosed. “This acquisition represents a pivotal step in advancing critical solutions for epilepsy care. By uniting our strengths, we’re enhancing our ability to provide end-to-end support for epilepsy—from accurate diagnosis to advanced interventions,” Roy Sakai, Nihon Kohden President.